{"id":"https://openalex.org/W7225651702","doi":"https://doi.org/10.18860/al.v14i2.44929","title":"Targeting AKT1 in Oral Cancer: In Silico Insights from Chrysanthemum morifolium Phytoconstituents","display_name":"Targeting AKT1 in Oral Cancer: In Silico Insights from Chrysanthemum morifolium Phytoconstituents","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225651702","doi":"https://doi.org/10.18860/al.v14i2.44929"},"language":"en","primary_location":{"id":"doi:10.18860/al.v14i2.44929","doi":"https://doi.org/10.18860/al.v14i2.44929","is_oa":true,"landing_page_url":"https://doi.org/10.18860/al.v14i2.44929","pdf_url":"https://ejournal.uin-malang.ac.id/index.php/Kimia/article/download/44929/14584","source":{"id":"https://openalex.org/S2738224989","display_name":"ALCHEMY Journal of Chemistry","issn_l":"2086-1710","issn":["2086-1710","2460-6871"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310314932","host_organization_name":"Universitas Islam Negeri Maulana Malik Ibrahim","host_organization_lineage":["https://openalex.org/P4310314932"],"host_organization_lineage_names":["Universitas Islam Negeri Maulana Malik Ibrahim"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ALCHEMY:Journal of Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://ejournal.uin-malang.ac.id/index.php/Kimia/article/download/44929/14584","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161332856","display_name":"Fawwaz Sirajuddin Haris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91819753","display_name":"Padjadjaran University","ror":"https://ror.org/00xqf8t64","country_code":"ID","type":"education","lineage":["https://openalex.org/I91819753"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Fawwaz Sirajuddin Haris","raw_affiliation_strings":["Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java","institution_ids":["https://openalex.org/I91819753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161325596","display_name":"Salsabila Tri Damayanti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91819753","display_name":"Padjadjaran University","ror":"https://ror.org/00xqf8t64","country_code":"ID","type":"education","lineage":["https://openalex.org/I91819753"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Salsabila Tri Damayanti","raw_affiliation_strings":["Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java","institution_ids":["https://openalex.org/I91819753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161351259","display_name":"Prisca Valensia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91819753","display_name":"Padjadjaran University","ror":"https://ror.org/00xqf8t64","country_code":"ID","type":"education","lineage":["https://openalex.org/I91819753"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Prisca Valensia","raw_affiliation_strings":["Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java","institution_ids":["https://openalex.org/I91819753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161318761","display_name":"Nabila Meysun Mardiana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91819753","display_name":"Padjadjaran University","ror":"https://ror.org/00xqf8t64","country_code":"ID","type":"education","lineage":["https://openalex.org/I91819753"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Nabila Meysun Mardiana","raw_affiliation_strings":["Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java","institution_ids":["https://openalex.org/I91819753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161306573","display_name":"Syarif Rahmat Aziz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91819753","display_name":"Padjadjaran University","ror":"https://ror.org/00xqf8t64","country_code":"ID","type":"education","lineage":["https://openalex.org/I91819753"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Syarif Rahmat Aziz","raw_affiliation_strings":["Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java","institution_ids":["https://openalex.org/I91819753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161349874","display_name":"Fasya Assyla Anjani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91819753","display_name":"Padjadjaran University","ror":"https://ror.org/00xqf8t64","country_code":"ID","type":"education","lineage":["https://openalex.org/I91819753"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Fasya Assyla Anjani","raw_affiliation_strings":["Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java","institution_ids":["https://openalex.org/I91819753"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075592755","display_name":"Dhania Novitasari","orcid":"https://orcid.org/0000-0002-5661-8841","observed_orcids":["https://orcid.org/0000-0002-5661-8841"]},"institutions":[{"id":"https://openalex.org/I91819753","display_name":"Padjadjaran University","ror":"https://ror.org/00xqf8t64","country_code":"ID","type":"education","lineage":["https://openalex.org/I91819753"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Dhania Novitasari","raw_affiliation_strings":["Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, West Java","institution_ids":["https://openalex.org/I91819753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I91819753"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"2","first_page":"61","last_page":"83"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12257","display_name":"Bioactive natural compounds","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-squamous-cell-carcinoma","display_name":"oral squamous cell carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chrysanthemum-morifolium","display_name":"Chrysanthemum morifolium","score":0.9990000128746033},{"id":"https://openalex.org/keywords/phytochemical-constituents","display_name":"phytochemical constituents","score":0.7979999780654907},{"id":"https://openalex.org/keywords/apigenin","display_name":"apigenin","score":0.875},{"id":"https://openalex.org/keywords/apigenin-7-o-glucuronide","display_name":"apigenin-7-O-glucuronide","score":0.9169999957084656},{"id":"https://openalex.org/keywords/apigenin-7-o-glucoside","display_name":"apigenin-7-O-glucoside","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.9779999852180481},{"id":"https://openalex.org/keywords/admet-prediction","display_name":"ADMET prediction","score":0.8299999833106995},{"id":"https://openalex.org/keywords/pharmacophore-modeling","display_name":"pharmacophore modeling","score":0.8059999942779541},{"id":"https://openalex.org/keywords/drug-likeness","display_name":"drug-likeness","score":0.765999972820282},{"id":"https://openalex.org/keywords/anticancer-natural-products","display_name":"anticancer natural products","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.9692000150680542},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.8514999747276306},{"id":"https://openalex.org/C2778609962","wikidata":"https://www.wikidata.org/wiki/Q424567","display_name":"Apigenin","level":4,"score":0.7825999855995178},{"id":"https://openalex.org/C154137905","wikidata":"https://www.wikidata.org/wiki/Q17816452","display_name":"AKT1","level":4,"score":0.6215000152587891},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5659999847412109},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5238999724388123},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.5212000012397766},{"id":"https://openalex.org/C103697762","wikidata":"https://www.wikidata.org/wiki/Q4112105","display_name":"Virtual screening","level":3,"score":0.46549999713897705},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4618000090122223},{"id":"https://openalex.org/C2777626555","wikidata":"https://www.wikidata.org/wiki/Q156109","display_name":"Thymelaeaceae","level":2,"score":0.4456999897956848},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4343999922275543},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.427700012922287},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.32199999690055847},{"id":"https://openalex.org/C2994372470","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell lines","level":4,"score":0.3154999911785126},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.314300000667572},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3142000138759613},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2955000102519989},{"id":"https://openalex.org/C2778836808","wikidata":"https://www.wikidata.org/wiki/Q424940","display_name":"Moxifloxacin","level":3,"score":0.28200000524520874},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27619999647140503},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.274399995803833},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.26350000500679016},{"id":"https://openalex.org/C2991691389","wikidata":"https://www.wikidata.org/wiki/Q901227","display_name":"Active compound","level":2,"score":0.2597000002861023},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.25940001010894775},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.25780001282691956},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.25769999623298645},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.2565000057220459}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.18860/al.v14i2.44929","doi":"https://doi.org/10.18860/al.v14i2.44929","is_oa":true,"landing_page_url":"https://doi.org/10.18860/al.v14i2.44929","pdf_url":"https://ejournal.uin-malang.ac.id/index.php/Kimia/article/download/44929/14584","source":{"id":"https://openalex.org/S2738224989","display_name":"ALCHEMY Journal of Chemistry","issn_l":"2086-1710","issn":["2086-1710","2460-6871"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310314932","host_organization_name":"Universitas Islam Negeri Maulana Malik Ibrahim","host_organization_lineage":["https://openalex.org/P4310314932"],"host_organization_lineage_names":["Universitas Islam Negeri Maulana Malik Ibrahim"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ALCHEMY:Journal of Chemistry","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.18860/al.v14i2.44929","doi":"https://doi.org/10.18860/al.v14i2.44929","is_oa":true,"landing_page_url":"https://doi.org/10.18860/al.v14i2.44929","pdf_url":"https://ejournal.uin-malang.ac.id/index.php/Kimia/article/download/44929/14584","source":{"id":"https://openalex.org/S2738224989","display_name":"ALCHEMY Journal of Chemistry","issn_l":"2086-1710","issn":["2086-1710","2460-6871"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310314932","host_organization_name":"Universitas Islam Negeri Maulana Malik Ibrahim","host_organization_lineage":["https://openalex.org/P4310314932"],"host_organization_lineage_names":["Universitas Islam Negeri Maulana Malik Ibrahim"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ALCHEMY:Journal of Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225651702.pdf","grobid_xml":"https://content.openalex.org/works/W7225651702.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W2765644644"],"related_works":["https://openalex.org/W4283741076","https://openalex.org/W4407144274","https://openalex.org/W4206955473","https://openalex.org/W4400590520","https://openalex.org/W4391860617","https://openalex.org/W6977315197","https://openalex.org/W6977316438","https://openalex.org/W4400057608","https://openalex.org/W4413114127","https://openalex.org/W4410247058"],"abstract_inverted_index":{"Oral":[0],"squamous":[1],"cell":[2,35],"carcinoma":[3],"(OSCC)":[4],"is":[5],"a":[6,30,140,164,204,225],"prevalent":[7],"type":[8],"of":[9,20,47,66,100,124,144,154,167,185,208,216,233],"oral":[10],"cancer":[11,34],"known":[12],"to":[13,43],"be":[14],"closely":[15],"associated":[16],"with":[17,104,120,163,198],"the":[18,21,25,45,88,116,129,135,149,159,174,183,191,211,231],"activation":[19],"PI3K/AKT/mTOR":[22],"pathway,":[23],"particularly":[24],"AKT1":[26,56,89,227],"protein,":[27],"which":[28,170],"plays":[29],"critical":[31],"role":[32],"in":[33,61,115,241,244],"proliferation,":[36],"migration,":[37],"and":[38,84,210,236,243],"survival.":[39],"This":[40],"study":[41],"aims":[42],"evaluate":[44],"potential":[46,223],"bioactive":[48,68],"compounds":[49,69,102,109,130],"from":[50],"Chrysanthemum":[51],"flowers":[52],"(Chrysanthemum":[53],"morifolium)":[54],"as":[55,113,224],"inhibitor":[57,228],"candidates":[58],"using":[59,134],"an":[60,121],"silico":[62],"approach.":[63],"A":[64],"total":[65],"30":[67,101],"were":[70,110,132],"then":[71,131],"analyzed":[72],"through":[73,240],"drug-likeness":[74],"assessment":[75],"based":[76,181],"on":[77,182],"Lipinski\u2019s":[78,105,199],"rule,":[79,106,200],"ADME-Tox":[80,202],"prediction,":[81],"pharmacophore":[82,118,151,205],"screening,":[83],"molecular":[85],"docking":[86,127],"against":[87],"receptor":[90],"(PDB":[91],"ID:":[92],"3CQW).":[93],"The":[94],"results":[95],"revealed":[96],"that":[97],"17":[98],"out":[99],"complied":[103],"while":[107],"all":[108,186],"successfully":[111],"identified":[112],"hits":[114],"best":[117,160],"model":[119],"AUC":[122],"value":[123,143,215],"0.70.":[125],"Molecular":[126],"for":[128,230],"validated":[133],"protein\u2019s":[136],"original":[137],"ligand,":[138],"yielding":[139],"reliable":[141],"RMSD":[142],"0.76":[145],"\u212b.":[146],"Apigenin-7-O-glucuronide":[147],"exhibited":[148,190],"highest":[150],"fit":[152,206],"score":[153,207],"34.42,":[155],"whereas":[156],"apigenin-7-O-glucoside":[157],"demonstrated":[158],"binding":[161,165],"affinity":[162],"energy":[166],"-10.29":[168],"kcal/mol,":[169],"was":[171],"lower":[172],"than":[173],"reference":[175],"compound":[176],"Capivasertib":[177],"(-9.52":[178],"kcal/mol).":[179],"However,":[180],"integration":[184],"evaluated":[187],"parameters,":[188],"apigenin":[189,220],"most":[192],"balanced":[193],"profile,":[194],"characterized":[195],"by":[196],"compliance":[197],"favorable":[201],"properties,":[203],"34.22,":[209],"lowest":[212],"inhibition":[213],"constant":[214],"0.00193":[217],"\u00b5M.":[218],"Collectively,":[219],"holds":[221],"strong":[222],"promising":[226],"candidate":[229],"development":[232],"OSCC":[234],"therapeutics":[235],"warrants":[237],"further":[238],"investigation":[239],"vitro":[242],"vivo":[245],"studies.":[246]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}